All Stories

  1. Detection of mild cognitive impairment in middle-aged and older adults with obstructive sleep apnoea: does excessive daytime sleepiness play a role?
  2. The role of vitamin D in obstructive sleep apnoea syndrome
  3. Mean Platelet Volume and Platelet Distribution Width in Patients With Obstructive Sleep Apnea Syndrome and Concurrent Chronic Obstructive Pulmonary Disease
  4. Vitamin D Levels in Middle-Aged Patients with Obstructive Sleep Apnoea Syndrome
  5. Cardiovascular Risk Assessment in a Cohort of Newly Diagnosed Patients with Obstructive Sleep Apnea Syndrome
  6. New developments in the management of COPD: clinical utility of indacaterol 75 µg
  7. Is There Evidence of Early Vascular Disease in Patients with Obstructive Sleep Apnoea Without Known Comorbidities? Preliminary Findings
  8. Can We Predict the Survival of Idiopathic Pulmonary Fibrosis Patients? Sleep Must Be Re-appreciated
  9. Increased incidence of autoimmune markers in patients with combined pulmonary fibrosis and emphysema
  10. A fatty meal aggravates apnea and increases sleep in patients with obstructive sleep apnea
  11. Subjective sleep quality in lung cancer patients before and after chemotherapy
  12. Continuous Positive Airway Pressure in Obstructive Sleep Apnea Syndrome and Prehypertension
  13. Increased Expression of Epidermal Growth Factor Receptor (EGF-R) in Patients with Different Forms of Lung Fibrosis
  14. Expression of Hypoxia-Inducible Factor (HIF)-1a-Vascular Endothelial Growth Factor (VEGF)-Inhibitory Growth Factor (ING)-4- axis in sarcoidosis patients
  15. Indacaterol: a new long-acting β2-agonist in the management of chronic obstructive pulmonary disease
  16. Metabolic Disorders in Obstructive Sleep Apnea
  17. Letter to the Editor Obstructive sleep apnoea syndrome and cardiovascular risk
  18. Lung Cancer and Interstitial Lung Diseases: A Systematic Review
  19. Continuous Positive Airway Pressure Treatment: Effect on Serum Lipids in Patients with Obstructive Sleep Apnoea
  20. Long-term respiratory follow-up of H1N1 infection
  21. Low-pressure pulmonary artery aneurysm presenting with pulmonary embolism: a case series
  22. The cost of COPD exacerbations: A university hospital – based study in Greece
  23. Are there any differences in clinical and laboratory findings on admission between H1N1 positive and negative patients with flu-like symptoms?
  24. Sleepiness as a marker of glucose deregulation in obstructive sleep apnea
  25. Continuous positive airway pressure to improve insulin resistance and glucose homeostasis in sleep apnea
  26. "Are there any differences in clinical and laboratory findings on admission between H1N1 positive and negative patients with flu-like symptoms?"
  27. Pleural Effusions and Thoracentesis in Patients with Hematological Malignancies
  28. Effect of continuous positive airway pressure therapy on a large hemangioma complicated with obstructive sleep apnea syndrome: a case report
  29. Obstructive Sleep Apnea Aggravates Glycemic Control across the Continuum of Glucose Homeostasis
  30. Work Productivity in Obstructive Sleep Apnea Patients
  31. Prevalence and clinical characteristics of obesity hypoventilation syndrome among individuals reporting sleep-related breathing symptoms in northern Greece
  32. Continuous Positive Airway Pressure Treatment in Patients with Sleep Apnoea: Does it Really Improve Glucose Metabolism?
  33. Predictors of obstructive sleep apnea in males with metabolic syndrome
  34. Respiratory Muscle Strength and Lung Function in Patients Undergoing Medical Thoracoscopy
  35. Reduction of Serum Retinol-Binding Protein-4 Levels in Nondiabetic Obstructive Sleep Apnea Patients under Continuous Positive Airway Pressure Treatment
  36. Inflammatory Markers in Middle-Aged Obese Subjects: Does Obstructive Sleep Apnea Syndrome Play a Role?
  37. Acute fibrinous and organising pneumonia: a case report and review of the literature
  38. Markers of glycemic control and insulin resistance in non-diabetic patients with Obstructive Sleep Apnea Hypopnea Syndrome: Does adherence to CPAP treatment improve glycemic control?
  39. Global Impairment of CD4+CD25+FOXP3+Regulatory T Cells in Idiopathic Pulmonary Fibrosis
  40. Plasma visfatin levels in severe obstructive sleep apnea—hypopnea syndrome
  41. Down-regulation of the inhibitor of growth family member 4 (ING4) in different forms of pulmonary fibrosis
  42. Recombinant tissue plasminogen activator in the treatment of pleural infections in adults
  43. Post-intubation pulmonary embolism and tracheal stenosis: A case report and review of the literature
  44. Rare Cases of Primary Pleural Hodgkin and Non-Hodgkin Lymphomas
  45. Current Pharmacological Treatment of Pulmonary Arterial Hypertension
  46. Effect of Continuous Positive Airway Pressure Treatment on Serum Cardiovascular Risk Factors in Patients With Obstructive Sleep Apnea-Hypopnea Syndrome
  47. Role of CD146 in Detection of Apoptotic Circulating Endothelial Cells in Obstructive Sleep Apnea
  48. Mycoplasma pneumoniae causing familial infection and acute severe respiratory failure